Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Non-cash Items (2020 - 2025)

Historic Non-cash Items for Journey Medical (DERM) over the last 6 years, with Q3 2025 value amounting to $5.5 million.

  • Journey Medical's Non-cash Items fell 4797.77% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year decrease of 4797.77%. This contributed to the annual value of $6.2 billion for FY2024, which is 7993.99% up from last year.
  • Latest data reveals that Journey Medical reported Non-cash Items of $5.5 million as of Q3 2025, which was down 4797.77% from $14.7 million recorded in Q2 2025.
  • Journey Medical's 5-year Non-cash Items high stood at $9.7 billion for Q4 2021, and its period low was $1.6 million during Q1 2023.
  • Its 5-year average for Non-cash Items is $1.3 billion, with a median of $8.5 million in 2022.
  • Its Non-cash Items has fluctuated over the past 5 years, first surged by 12166712.06% in 2021, then plummeted by 8182.64% in 2023.
  • Journey Medical's Non-cash Items (Quarter) stood at $9.7 billion in 2021, then crashed by 77.04% to $2.2 billion in 2022, then surged by 55.16% to $3.4 billion in 2023, then skyrocketed by 79.94% to $6.2 billion in 2024, then crashed by 99.91% to $5.5 million in 2025.
  • Its Non-cash Items was $5.5 million in Q3 2025, compared to $14.7 million in Q2 2025 and $10.9 million in Q1 2025.